Accès direct au contenu


NMNS - Version française > NMNS - Activités de recherche > NMNS - Publications > NMNS - Publications 2012-2013

Publications 2012-2013

2013 : 9 publications

  • J. Gautier, E. Munnier, L. Douziech-Eyrolles, A. Paillard, P. Dubois, I. Chourpa

SERS spectroscopic approach to study doxorubicin complexes with Fe(2+) ions and drug release from SPION-based nanocarriers.
Analyst 2013. 138(24):7354-61. doi: 10.1039/c3an00787a. IF 3,9

  • J. Gautier, E. Allard-Vannier, K. Hervé-Aubert, M. Soucé, I. Chourpa

Design strategies of hybrid metallic nanoparticles for theragnostic applications.
Nanotechnology 2013. 24(43): 432002. doi: 10.1088/0957-4484/24/43/432002. IF 3,7

  • M. Chiper, K. Hervé Aubert, A. Augé, J.F. Fouquenet, M. Soucé, I. Chourpa

Colloidal stability and thermo-responsive properties of iron oxide nanoparticles coated with polymers: advantages of Pluronic® F68-PEG mixture.
Nanotechnology 2013. 24(39): 395605 (11pp). doi: 10.1088/0957-4484/24/39/395605. IF 3,7

  • S. David, H. Marchais, K. Hervé-Aubert, D. Bedin, A.S. Garin, Hoinard C, I. Chourpa

Use of experimental design methodology for the development of new magnetic siRNA nanovectors (MSN).
Int J Pharm. 2013.454(2): 660-7. doi: 10.1016/j.ijpharm.2013.05.051. IF 4,1

  • J. Gautier, E. Allard-Vannier, E. Munnier, M. Soucé, I. Chourpa

Recent advances in theranostic nanocarriers of doxorubicin based on iron oxide and gold nanoparticles.
J Control Release. 2013. 169(1-2): 48-61. doi: 10.1016/j.jconrel.2013.03.018. IF 7,7

  • S. David, C. Passirani, N. Carmoy, M. Morille, M. Mevel, J.P. Benoit, T. Montier, B. Pitard

DNA nanocarriers for systemic administration – characterization and in vivo bioimaging in healthy mice.
Mol Ther Nucleic Acids. 2013. 2: e64. doi: mtna.2012.56. IF 6,4

  • S.M. Ali, F. Bonnier, A. Tfayli, H. Lambkin, K. Flynn, V. McDonagh, C. Healy, T. Clive Lee, F.M. Lyng, H.J. Byrne

Raman spectroscopic analysis of human skin tissue sections ex-vivo: evaluation of the effects of tissue processing and dewaxing.
J Biomed Opt. 2013. 18(6): 061202. doi: 10.1117/1.JBO.18.6.061202. IF 2,8

  • S.M. Ali, F. Bonnier, H. Lambkin, K. Flynn, V. McDonagh, C. Healy, T.C. Lee, F.M. Lyng, H.J. Byrne

A comparison of Raman, FTIR and ATR-FTIR micro spectroscopy for imaging human skin tissue sections.
Anal. Meth. 2013. 5: 2281-2291 IF 1,9

  • S.M. Ali, F. Bonnier, K. Ptasinski, H. Lambkin, K. Flynn, F.M. Lyng, H.J. Byrne

Raman spectroscopic mapping for the analysis of solar radiation induced skin damage.
Analyst 2013. 138(14): 3946-56. doi: 10.1039/c3an36617k IF 3,9



2012 : 13 publications

  • E. Allard-Vannier, S. Cohen-Jonathan, J. Gautier, K Hervé-Aubert, E. Munnier, M. Soucé, P. Legras, C. Passirani, I. Chourpa

Pegylated magnetic nanocarriers for doxorubicin delivery: a quantitative determination of stealthiness in vitro and in vivo.
Eur J Pharm Biopharm. 2012. 81(3):498-505. doi: 10.1016/j.ejpb.2012.04.002. IF 4,2

  • K. Kaaki, K. Hervé-Aubert, M. Chiper, A. Shkilnyy, M. Soucé, R. Benoit, A. Paillard, P. Dubois, M.L. Saboungi, I. Chourpa

Magnetic nanocarriers of doxorubicin coated with poly(ethylene glycol) and folic acid: relation between coating structure, surface properties, colloidal stability, and cancer cell targeting.
Langmuir 2012. 28(2):1496-505. doi: 10.1021/la2037845. IF 4,2

  • J. Gautier, E. Munnier, A. Paillard, K. Hervé, L. Douziech-Eyrolles, M. Soucé, P. Dubois, I. Chourpa

A pharmaceutical study of doxorubicin-loaded PEGylated nanoparticles for magnetic drug targeting.
Int J Pharm. 2012. 423(1):16-25. doi: 10.1016/j.ijpharm.2011.06.010. IF 3,8

  • J. Fichot, R. Heyd, C. Josserand, I. Chourpa, E. Gombart, J.F. Tranchant, M.L. Saboungi

Patterned surfaces in the drying of films composed of water, polymer, and alcohol.
Phys Rev E Stat Nonlin Soft Matter Phys. 2012. 86(6 Pt 1):061601. IF 2,3

  • N.T. Huynh, C. Passirani, E. Allard-Vannier, L. Lemaire, J. Roux, E. Garcion, A. Vessieres, et al.

Administration-dependent efficacy of ferrociphenol lipid nanocapsules for the treatment of intracranial 9L rat gliosarcoma.
Int. J. Pharm. 2012. 423: 55–62. IF 3,8

  • S. David, N. Carmoy, P. Resnier, C. Denis, L. Misery, B. Pitard, J.P. Benoit, C. Passirani, T. Montier

In vivo imaging of DNA lipid nanocapsules after systemic administration in a melanoma mouse model.
Int J Pharm. 2012, 423: 108-15. IF 3,8

  • S. David, T. Montier, N. Carmoy, P. Resnier, A. Clavreul, M. Mével, B. Pitard, J.P. Benoit, C. Passirani

Treatment efficacy of dna lipid nanocapsules and dna multimodular systems after systemic administration in a human glioma model.
J Gene Med. 2012, 14: 769-75. IF 2,0

  • S David, P. Resnier, A. Guillot, B. Pitard, J.P. Benoit, C. Passirani

SiRNA LNCs - a novel platform of lipid nanocapsules for systemic siRNA administration.
Eur J Pharm Biopharm. 2012. 81 : 448-52. IF 4,2

  • F. Bonnier, H.J. Byrne

Understanding the molecular information contained in principal component analysis of vibrational spectra of biological systems.
Analyst 2012. 137(2): 322-332. IF 3,9

  • J. Dorney, F. Bonnier, A. Garcia, A. Casey, G. Chambers, H.J. Byrne

Identifying and localizing intracellular nanoparticles using Raman spectroscopy.
Analyst 2012. 137(5) : 1111-1119. IF 3,9

  • L.L. McManus, F. Bonnier, G.A. Burke, B.J. Meenan, A.R. Boyd, H.J. Byrne

Assessment of an osteoblast-like cell line as a model for human primary osteoblasts using Raman spectroscopy.
Analyst 2012. 137(7): 1559-1569. IF 3,9

  • F. Bonnier, S.M. Ali, P. Knief, H. Lambkin, K. Flynn, V. McDonagh, C. Healy, T.C. Lee, F.M. Lyng, H.J. Byrne

Analysis of human skin by Raman microspectroscopy: Dealing with the background.
Vibrat. Spectrosc. 2012. 61: 124-132. IF 1,7

  • M.E. Keating, F. Bonnier, H.J. Byrne

Spectral cross-correlation as a supervised approach for the analysis of complex Raman datasets: the case of nanoparticles in biological cells.
Analyst 2012. 137(24): 5792-5802. IF 3,9

 


  • Facebook
  • twitter
  • google
  • imprimer
  • version PDF
  • Envoyer cette page

Retour au site institutionnel